Biotechnology sector - Our Business Insight recommendation from Biotechnology is already up 30% while the SENSEX is down 0.98% !!!

The Indian biotechnology sector is one of the fastest growing knowledge-based sectors in India and same is the case with our Business Insight (under Penny stock package) recommendation from the Biotechnology sector.

Biotechnology is expected to play a key role in shaping India's rapidly developing economy. The Indian biotech sector’s overall turnover in 2008-09 was US$ 2.51 billion, as compared to US$ 2.13 billion in 2007-08. Bio-pharma contributed US$ 1.6 billion; bio-agri nearly US$ 311.28 million, bio-industrial segment US$ 99.19 million and bio-informatics grew 15 per cent to touch US$ 45.65 million.

India is also gaining importance as a clinical trial destination. The global clinical research outsourcing market is projected to touch US$ 23 billion by 2011, with consultancy firm KPMG estimating that India will corner 15 per cent of this in two years. Moreover, according to joint study by FICCI and E&Y, the industry-sponsored Phase II, Phase III clinical trial study sites in India have grown by 116 per cent over the last 15 months with the country moving from rank 18 to 12 across the 60 most active countries.

While talking so much on Biotechnology, let's get into the details of various segments under the same head:

Bio Pharmaceuticals

• Largest contributor to revenues of the biotech industry. Recorded sales in excess of US$ 1.72 billion in 2008–09.
• Accounted for 67 percent of the total industry revenues, registering 16 percent growth over the last fiscal.

Bio Services

• Bio Services is the second largest contributor to the industry with a 17 percent share of the industry.
• India offers a US$ 1 billion opportunity in clinical trials alone.
• Global companies view India as a favorite destination for outsourcing services.

Bio Informatics

• Bioinformatics is a US$ 48.4 million (2008-09) opportunity in India and is rapidly growing.
• Department of Biotechnology (DBT) has taken initiatives to link 63 bioinformatics centers in India.

Bio Industrial

• Bio Industrial segment touched US$ 105 million in 2008–09 witnessing a growth of 17 percent over the previous fiscal.
• Many opportunities exist in manufacturing industrial enzymes in India for export purposes.

India is already being globally recognized as a manufacturer of economical, high quality bulk drugs and formulations. With a huge base of talented, skilled and cost competitive manpower, and a well-developed scientific infrastructure, India has great potential to become a leading global player in biotechnology.

Now talking so much about the rapid growth of Biotechnology sector makes no sense until we benefit out of the same. So, why not be a part of this growth and invest in some listed company poised to grow multi-fold in the next few years.

Well, where else could you have found a solution other than MPS (Penny stock package). As I said, our Business Insight recommendation from the bio-tech sector is growing rapidly and has already appreciated by 30% since the time we recommended while the SENSEX is down by 0.98%. When you get a company operating in the above mentioned segments, backed by a team of highly qualified Management and Scientists, you are bound to make huge money on your investment.


For any inquiries regarding the subscription to our Penny Stock package, please contact Sandeep Jain @ 91 98867 36791 or info@hbjcapital.com


MPS - Penny stock package
Email: Ekansh@hbjcapital.com